GLP-1s can affect how often some people need to take time off work, study finds

Savings to the overall health care economy from GLP-1 drugs have yet to be proven, but researchers have found evidence that health benefits could spill into the labor market. A study of workers in Denmark showed a 17.3 percent decline in long-term sick leave among those who were treated with Ozempi...

Redirecting to full article...